Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02689531 · ClinicalTrials.gov registry record
CTTI Risk Factors for HABP/VABP Study
A clinical trial of Pneumonia, Bacterial and Pneumonia, Ventilator-Associated, sponsored by Duke University.
- Completed
- Registry status
- 7,530
- Enrollment target
- 15
- Study locations
NCT02689531: Completed study of Pneumonia, Bacterial and Pneumonia, Ventilator-Associated, sponsored by Duke University.
NCT02689531 is a study of Pneumonia, Bacterial and Pneumonia, Ventilator-Associated that has completed, run by Duke University. The registered enrollment target is 7,530 participants, above the 273-participant average among 7 other Pneumonia, Bacterial trials with a reported enrollment target (2658% higher). The trial reports 15 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02689531, a study of Pneumonia, Bacterial and Pneumonia, Ventilator-Associated, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 7,530 participants
- Enrollment target
- 15
- Study locations
Study Summary
The purpose of this study is to better define the intensive care unit population at highest risk for developing Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP).
Primary Outcome
Estimate the rate of HABP/VABP diagnosis in ICU subjects who meet the predetermined high-risk criteria.
Conditions Studied
Study Locations (15)
Michigan
- - Detroit
- - Royal Oak
Pennsylvania
- - Philadelphia
- - Pittsburgh
Alabama
- - Birmingham
California
- - Los Angeles
Illinois
- - Chicago
Kentucky
- - Louisville
Louisiana
- - New Orleans
Missouri
- - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,530 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-02 |
What the finished NCT02689531 record still lists
NCT02689531 is an observational study that tracks outcomes without assigning an intervention. Its 7,530 participants enrollment target places it among the larger protocols in the corpus, above the 273-participant average among 7 other Pneumonia, Bacterial trials with a reported enrollment target (2658% higher).
The record links to 3 conditions, with Pneumonia, Bacterial appearing as the primary indexed condition, and to 0 interventions.
NCT02689531 lists 15 locations in 13 states (Michigan, Pennsylvania, Alabama).
Frequently Asked Questions
What is clinical trial NCT02689531 about?
NCT02689531 is a clinical study titled "CTTI Risk Factors for HABP/VABP Study". The purpose of this study is to better define the intensive care unit population at highest risk for developing Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia (HABP/VABP).
What is the current status of trial NCT02689531?
This trial is currently completed. The enrollment target is 7,530 participants. The study started on 2016-02. Estimated completion is 2018-02.
What conditions does trial NCT02689531 study?
This clinical trial studies the following conditions: Pneumonia, Bacterial, Pneumonia, Ventilator-Associated, Pneumonia, Hospital-Acquired.
Who is sponsoring clinical trial NCT02689531?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02689531 being conducted?
This trial has 15 study locations across Alabama, California, Illinois, Kentucky, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pneumonia, Bacterial
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia
ACTIVE NOT RECRUITING · Phase 2
-
Discharge Stewardship in Children's Hospitals
ACTIVE NOT RECRUITING · NA
-
Pneumonia Direct Pilot
COMPLETED
-
Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
COMPLETED · Phase 2
-
Urease Breath Test for Rapid Characterization of Pneumonia
COMPLETED
-
Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00439049 · 7,500 participants
Substance Abuse Pre-Treatment Screening Study
- NCT04809740 · 7,500 participants · NA
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
- NCT05199701 · 7,500 participants · NA
Prospective Case Collection Study for New Mammography Technologies
- NCT06112418 · 7,500 participants · NA
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia